The Impact of Preoperative Facial Nerve Weakness and Facial Nerve Outcomes in the Management of Patients With Parotid Metastases of Cutaneous Squamous Cell Carcinoma
Head & Neck · 2025
DOI: 10.1002/hed.28005 ↗Kurz gefasst
Fachartikel in der Zeitschrift Head & Neck, 2025. Verfasst von Vivian Lin und 9 weiteren Autor:innen. Beteiligte Einrichtung: Chris O'Brien Lifehouse, Sydney Head and Neck Cancer Institute, Camperdown, Australia. Hauptthemen laut MEDLINE: Parotid Neoplasms, Skin Neoplasms, Carcinoma, Squamous Cell, Facial Nerve. Die Arbeit nennt 29 Literaturangaben.
Abstract (Originalsprache)
Background
Cutaneous squamous cell carcinomas (cSCC) metastasizing to the parotid gland can cause facial nerve (FN) dysfunction secondary to direct invasion, perineural spread, or surgical ablation. This study aims to characterize the prevalence of preoperative FN involvement in metastatic cSCC to the parotid and identify risk factors resulting in FN sacrifice.
Methods
Patients with parotid metastases from cSCC, treated surgically with parotidectomy with curative intent were identified through a retrospective cohort analysis of a prospectively maintained Sydney Head and Neck database from 1992 to 2021.
Results
Of 408 patients identified, 39 (10%) were found to have preoperative FN weakness, of which 41% underwent concurrent temporal bone resection compared to 9.1% for the overall cohort. All patients with preoperative FN weakness underwent FN sacrifice. FN sacrifice occurred in n = 145 (36%), of which 88 (61%) required sacrifice of a trunk or division. The 5‐year disease free survival and disease specific survival was worse for patients requiring sacrifice of the FN trunk compared to no sacrifice, however there was no difference in survival for patients requiring sacrifice of the FN division or branch. We found those with > 23.5 mm parotid deposits had an odds ratio of 9.9 for FN sacrifice (95% CI 3.0–32.8, p < 0.001).
Conclusions
Preoperative FN weakness was present in 10% of patients and 36% had some part of the FN sacrificed. There was no significant difference in outcomes for patients with and without preoperative FN weakness. Patients who undergo sacrifice of the FN trunk have worse survival compared to those not requiring FN sacrifice, however similar outcomes were observed in those requiring lessor degrees of FN sacrifice. The likelihood FN sacrifice rises with increasing parotid deposit size.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Chris O'Brien Lifehouse, Sydney Head and Neck Cancer Institute, Camperdown, Australia.
- Central Clinical School, Faculty of Medicine and Health Sciences, The University of Sydney, Sydney, Australia.
- Department of Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Camperdown, Australia.
- Royal Prince Alfred Hospital, The Royal Prince Alfred Institute of Academic Surgery, Camperdown, Australia.
- Department of Otolaryngology-Head & Neck Surgery, Faculty of Medicine and Health Sciences, Macquarie University, Sydney, Australia.
ORCID-Profile: Vivian Lin
Zitieren
APA
Lin, V., Zhang, M., Gupta, R., Elliott, M. S., Clark, J. R., Wykes, J. J., Ch'ng, S., Shannon, K. F., Palme, C. E., & Low, T. H. (2025). The Impact of Preoperative Facial Nerve Weakness and Facial Nerve Outcomes in the Management of Patients With Parotid Metastases of Cutaneous Squamous Cell Carcinoma. Head & Neck. https://doi.org/10.1002/hed.28005
Vancouver
Lin V, Zhang M, Gupta R, Elliott MS, Clark JR, Wykes JJ, et al. The Impact of Preoperative Facial Nerve Weakness and Facial Nerve Outcomes in the Management of Patients With Parotid Metastases of Cutaneous Squamous Cell Carcinoma. Head & Neck. 2025. doi:10.1002/hed.28005
BibTeX
@article{Lin2025,
author = {Lin, Vivian and Zhang, Michael and Gupta, Ruta and Elliott, Michael S and Clark, Jonathan R and Wykes, James J and Ch'ng, Sydney and Shannon, Kerwin F and Palme, Carsten E and Low, Tsu-Hui},
title = {The Impact of Preoperative Facial Nerve Weakness and Facial Nerve Outcomes in the Management of Patients With Parotid Metastases of Cutaneous Squamous Cell Carcinoma},
journal = {Head & Neck},
year = {2025},
doi = {10.1002/hed.28005}
}
EUVIMED